Aspergillus fumigatus synergistically enhances mite-induced allergic airway inflammation

Medical Science Monitor

Volumn 16, Issue 7, 2010, Pages 197-202

  Fukushima, Chizu ^a   Matsuse, Hiroto ^a   Fukahori, Susumu ^a   Tsuchida, Tomoko ^a   Kawano, Tetsuya ^a   Senjyu, Hideaki ^b   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Allergic bronchopulmonary aspergillosis (ABPA); Aspergillus fumigates; Bronchial asthma; Dermatophagoides farinae

Indexed keywords

CXCL3 CHEMOKINE; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 5; INTERLEUKIN 8; MUCIN 5AC; CYTOKINE; MUC5AC PROTEIN, MOUSE;

ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; ASTHMA; BRONCHUS MUCUS; DERMATOPHAGOIDES FARINAE; FEMALE; IMMUNE RESPONSE; INFLAMMATION; LUNG LAVAGE; MITE; MOUSE; MUCUS SECRETION; NONHUMAN; SENSITIZATION; TH2 CELL; ANIMAL; BAGG ALBINO MOUSE; CELL COUNT; CYTOLOGY; IMMUNOLOGY; LUNG; METABOLISM; MICROBIOLOGY; PATHOLOGY; PNEUMONIA; SECRETION;

ANIMALS; ASPERGILLUS FUMIGATUS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; CYTOKINES; FEMALE; LUNG; MICE; MICE, INBRED BALB C; MITES; MUCIN 5AC; PNEUMONIA;

EID: 77954786293     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Krug N, Frew AJ: The Th2 cell in asthma: initial expectations yet to be realized. Clin Exp Allergy, 1997; 27: 142-50.
2. Busse WW, Lemanske RF: Asthma [review]. N Engl J Med, 2001; 344: 350-62.
3. Alexis NE, Soukup J, Nierkens S, Becker S: Association between airway hyperreactivity and bronchial macrophage dysfunction in individuals with mild asthma. Am J Physiol Lung Cell Mol Physiol, 2001; 280: L369-75.
4. Doherty TM, Kastelein R, Menon S et al: Modulation of murine macrophage function by IL-13. J Immunol, 1993; 151: 7151-60.
5. Coste A, Linas MD, Cassaing S et al: A sub-inhibitory concentration of amphotericin B enhances candidastatic activity of interferon-gamma and interleukin-13-treated murine peritoneal macrophages. J Antimicrob Chemother, 2002; 49: 731-40.
6. Schmidt-Weber CB: Th 17 and Treg Cells Innovate the Th/Th2 Concept and Allergy Research. Chem Immunol Allergy, 2008; 94: 1-7.
7. Afshar R, Medoff BD, Luster AD: Allergic asthma: a tale of many T cells. Clin Exp Allergy, 2008; 38: 1847-57.
8. Gern JE, Busse WW: The role of viral infections in the natural history of asthma. J Allergy Clin Immunol, 2000; 106: 201-12.
9. Hall CB: Respiratory syncytial virus and parainfluenza virus. N Engl J Med, 2001; 344: 1917-28.
10. Ferreira A, Williams Z, Donninger H et al: Rhinovirus is associated with severe asthma exacerbations and raised nasal Interleukin-12. Respiration, 2002; 69: 136-42.
11. Lemanske RF Jr: Viruses and asthma: Inception, exacerbation, and possible prevention. J Pediatr, 2003; 142: S3-7.
12. Nicholson KG, Kent J, Ireland DC: Respiratory viruses and exacerbations of asthma in adults. Br Med J, 1993; 342: 1494-95.
13. Kondo Y, Matsuse H, Machida I et al: Effects of primary and secondary low-grade respiratory syncytial virus infections in a murine model of asthma. Clin Exp Allergy, 2004; 34: 1307-13.
14. Melbye H, Kongerud J, Vorland L: Reversible airflow limitation in adults with respiratory infection. Eur Respir J, 1994; 7: 1239-45.
15. Contoli M, Caramori G, Mallia P, Johnson S, Papi A: Mechanisms of respiratory virus-induced asthma exacerbations. Clin Exp Allergy, 2005; 35: 137-45.
16. Johnston SL, Martin RJ: Chlamydophila pneumoniae and Mycoplasma pneumoniae: a role in asthma pathogenesis? Am J Respir Crit Care Med, 2005; 172: 1078-89.
17. Matsuse H, Behera AK, Kumar M et al: Recurrent respiratory syncytial virus infections in allergen-sensitized mice lead to persistent airway inflammation and hyperresponsiveness. J Immunol, 2000; 164: 6583-92.
18. Kondo Y, Matsuse H, Machida I et al: Regulation of mite allergen-pulsed murine dendritic cells by respiratory syncytial virus. Am J Respir Crit Care Med, 2004; 169: 494-98.
19. Green BJ, Mitakakis TZ, Tovey ER: Allergen detection from 11 fungal species before and after germination. J Allergy Clin Immunol, 2003; 111: 285-89.
20. Nessa K, Palmberg L, Johard U et al: Reaction of human alveolar macrophage to exposure to Aspergillus fumigatus and inert particles. Environ Res, 1997; 75: 141
21. Gruning G, Kurup VP: Animal models of allergic bronchopulmonary aspergillosis. Frontiers in Bioscience, 2003; 8: 157-71.
22. Hogaboam CM, Blease K, Mehrad B et al: Chronic airway hyperreactivity, goblet cell hyperplasia, and peribronchial fibrosis during allergic airway disease induced by Aspergillus fumigatus. Am J Pathol, 2000; 156: 723-32.
23. Matsuda H, Kohno S, Maesaki S et al: Application of ubiquinone systems and electrophoretic comparison of enzymes to identification of clinical isolates of Aspergillus fumigates and several other species of Aspergillus. J. Clin. Microbiol 1992; 30: 1999-2005.
24. Otsubo T, Maruyama K, Maesaki S et al: Long-circulating immunoliposomal Amphotericin B against Invasive Pulmonary Aspergillosis in mice. Antimicrob Agents Chemother, 1998; 42: 40-44.
25. Kawano T, Matsuse H, Kondo Y et al: Cysteinyl leukotrienes induce nuclear factor kB activation and RANTES production in a murine model of asthma. J Allergy Clin Immunol, 2003; 112: 369-74.
26. Kaneko Y, Yanagihara K, Seki M et al: Clarithromycin inhibits overproduction of muc5ac core protein in murine model of diffuse panbronchiolitis. Am J Phisiol Lung Cell Mol Physiol, 2003; 285: L847-53.
27. Kobayashi T, Iijima K, Radhakrishnan S et al: Asthma-related environmental fungus, Alternaria, activates dendritic cells and produces potent Th2 adjuvant activity. J Immunol, 2009; 182: 2502-10.
28. Gao FS, Qiao JO, Zhang Y, Jin XQ: Chronic intranasal administration of Aspergillus fumigates spores leads to aggravation of airway inflammation and remodeling in asthmatic rats. Respirology, 2009; 14: 360-70.
29. Bossa S, Clavaud C, Giovannini G et al: Immune sensing of Aspergillus fumigates proteins, glycolipids, and polysaccharides and the impact on Th immunity and vaccination. J Immunol, 2009; 183: 2407-14.
30. Gibson PG, Wark PA, Simpson JL et al: Induced sputum IL-8 gene expression, neutrophil influx and MMP-9 in allergic bronchopulmonary aspergillosis. Eur Respir J, 2003; 21: 582-88.
31. Glaser AG, Kirsch AI, Zeller S et al: Molecular and immunological characterization of Asp f34, a novel major cell wall allergen of Aspergillus fumigatus. Allergy, 2009; 64: 1144-51.
32. Cohn L: Mucus in chronic airway diseases: sorting out the sticky details. J Clin Invest, 2006; 116: 306-8.
33. Morcillo EJ, Cortijo J: Mucus and MUC in asthma. Curr Opin Pulm Med, 2006; 12: 1-6.
34. Stevens DA, Schwartz HJ, Lee JY et al: A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med, 2000; 342: 756-62.
35. Wark PAB, Hensley MJ, Saltos N et al: Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: A randomized controlled trial. J Allergy Clin Immunol, 2003; 111: 952-57.
36. Denning DW, O'Driscoll BR, Powell G et al: Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: The fungal asthma sensitization trial (FAST) study. Am J Respir Crit Care Med, 2009; 179: 11-18